1622-62-4|Flunitrazepam|5-(2-fluorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one|-范德生物科技公司

Flunitrazepam

NMR下载 COA and HPLC MSDS下载
names：
5-(2-fluorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one
CAS号：
1622-62-4
MDL Number：
MF(分子式)： C16H12FN3O3 MW(分子量)： 313.2832
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)
FMK15356-100mg	100mg	>98%	¥ 0.00	¥ 0.00		Get quote	- +	¥ 0.00

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Flunitrazepam
英文别名	Flunitrazepam, Narcozep, Rohypnol, Primun, Flunitrazepamum
CAS号	1622-62-4
Inchi	InChI=1S/C16H12FN3O3/c1-19-14-7-6-10(20(22)23)8-12(14)16(18-9-15(19)21)11-4-2-3-5-13(11)17/h2-8H,9H2,1H3
InchiKey	PPTYJKAXVCCBDU-UHFFFAOYSA-N
分子式 Formula	C16H12FN3O3
分子量 Molecular Weight	313.2832
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Flunitrazepam(CAS:1622-62-4):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Flunitrazepam is an intermediate acting benzodiazepine used as an hypnotic, sedative, anticonvulsant, anxiolytic, and skeletal muscle relaxant drug. In general, the prescription of flunitrazepam as a hypnotic is intended to be for short-term treatment of chronic or severe insomniacs not responsive to other hypnotics, especially in inpatients. Flunitrazepam is discontinued (DEA controlled substance).
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Smith KM, Larive LL, Romanelli F. Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate. Am J Health Syst Pharm. 2002 Jun 1;59(11):1067-76. Review. PubMed PMID: 12063892.

[2]Woods JH, Winger G. Abuse liability of flunitrazepam. J Clin Psychopharmacol. 1997 Jun;17(3 Suppl 2):1S-57S. Review. PubMed PMID: 9169981.

[3] Mattila MA, Larni HM. Flunitrazepam: a review of its pharmacological properties and therapeutic use. Drugs. 1980 Nov;20(5):353-74. Review. PubMed PMID: 6108205.

[4] Kaufmann RM, Frey R, Battista HJ, Kasper S. [Flunitrazepam and driving ability]. Fortschr Neurol Psychiatr. 2004 Sep;72(9):503-15. Review. German. PubMed PMID: 15365913.

[5] Druid H, Holmgren P, Ahlner J. Flunitrazepam: an evaluation of use, abuse and toxicity. Forensic Sci Int. 2001 Nov 1;122(2-3):136-41. Review. PubMed PMID: 11672967.

6: Waltzman ML. Flunitrazepam: a review of "roofies". Pediatr Emerg Care. 1999 Feb;15(1):59-60. Review. PubMed PMID: 10069317.7: Simmons MM, Cupp MJ. Use and abuse of flunitrazepam. Ann Pharmacother. 1998 Jan;32(1):117-9. Review. PubMed PMID: 9475831.8: Lampert A, Joly P, Thomine E, Ortoli JC, Lauret P. [Scleroderma-like syndrome with bullous morphea during treatment with 5-hydroxytryptophan, carbidopa and flunitrazepam]. Ann Dermatol Venereol. 1992;119(3):209-11. Review. French. PubMed PMID: 1605525.9: Amrein R. [The pharmacokinetics and metabolism of flunitrazepam]. Klin Anasthesiol Intensivther. 1978;(17):8-24. Review. German. PubMed PMID: 28445.10: Bergmann H. [Administration and dosage of flunitrazepam within the framework of general anesthesia]. Klin Anasthesiol Intensivther. 1978;(17):130-47. Review. German. PubMed PMID: 28435.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开